+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

From
From
From
FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUCELVAX QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUCELVAX QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUMIST QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUMIST QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Microbiome - Competitive landscape, 2023 - Product Thumbnail Image

Microbiome - Competitive landscape, 2023

  • Report
  • April 2023
  • 300 Pages
  • Global
From
Cancer Vaccines - Competitive landscape, 2023 - Product Thumbnail Image

Cancer Vaccines - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
Darbepoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Darbepoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Epoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Epoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Follitropin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Follitropin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pegfilgrastim- Biosimilar Insight, 2022 - Product Thumbnail Image

Pegfilgrastim- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Teriparatide- Biosimilar Insight, 2022 - Product Thumbnail Image

Teriparatide- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more